SOPHiA Genetics (SOPH) EBITDA (2020 - 2026)
SOPHiA Genetics (SOPH) EBITDA from Mar 31, 2020 to Mar 31, 2026. The TTM SOPHiA Genetics (SOPH) EBITDA is -$66M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
SOPHiA Genetics (SOPH) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +39.10% |
| 3 Years TTM | -4.10% |
| 5 Years TTM | +9.33% |
| All Time TTM | +9.33% |
Annual EBITDA change of SOPHiA Genetics (SOPH)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$15M | -76.34% |
| 2025 | -$61M | +20.96% |
| 2024 | -$51M | -27.04% |
| 2023 | -$70M | -14.50% |
| 2022 | -$81M | +17.52% |
| 2021 | -$69M | +82.26% |
| 2020 | -$38M | +23.58% |
| 2019 | -$31M | N/A |
Comparison SOPHiA Genetics (SOPH) five years EBITDA CAGR with competitors
SOPHiA Genetics (SOPH) five years EBITDA CAGR is 9.33%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| OPRX | OptimizeRx Corp | 77.72% | +733.18% |
| CCLD | CareCloud Inc | 73.90% | +692.17% |
| CCLDO | CareCloud Inc | 73.90% | +692.17% |
| SY | So-Young International Inc | 39.98% | +328.56% |
| DOCS | Doximity Inc - Class A | 32.10% | +244.10% |
| HQY | Healthequity Inc | 26.05% | +179.29% |
| VEEV | Veeva Systems Inc - Class A | 25.30% | +171.19% |
| HCAT | Health Catalyst Inc | 20.13% | +115.84% |
| SDGR | Schrodinger Inc | 18.03% | +93.30% |
| PRVA | Privia Health Group Inc | 10.68% | +14.44% |
| EVH | Evolent Health Inc - Class A | 9.64% | +3.31% |
| HSTM | Healthstream Inc | 9.04% | -3.11% |
| OMCL | Omnicell Inc | 0.63% | -93.27% |
| DRIO | DarioHealth Corp | 0.22% | -97.65% |